Abstract
Transcatheter aortic valve replacement has substantially grown in volume over the years, and increasingly is being used in patients with longer life expectancy, including younger patients. With increasing implantation of transcatheter heart valves (THV) the need for explantation of these devices with replacement of the aortic valve will also go up. Bioprosthetic valve endocarditis, along with paravalvular leaks and structural valve degeneration will be the leading causes requiring THV explantation and redo-aortic valve replacement (AVR). Given the cascade of trials in different populations and the rapid development cycle for THV, the patients, design and composition of the bioprostheses being explanted will vary considerably. However, many of the preoperative considerations, imaging and technical considerations in patients with a failed THV will be the same. Here, we highlight the technical steps to achieve a safe THV explantation and redo-AVR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Operative Techniques in Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
